Turning Concepts Into Products

The JAKK Group develops early stage medical technologies and assembles intellectual property. We are experts in the process of turning concepts into products that serve unmet clinical needs. The challenge of early stage development is to efficiently establish the value of a concept as a product, prior to making significant investments in infrastructure and management teams. At the JAKK Group, we meet this challenge by selecting the right opportunity for development and providing leadership, development expertise, resources, and business planning. We combine these development skills with appropriate fundraising through a broad range of contacts in venture capital, private equity, and corporate business development.

The JAKK Group is led by a seasoned entrepreneur that has established several venture backed companies. Together these companies have secured over $100 MM in venture capital financing from top tier firms and collectively employ over 100 people. These pioneering companies have developed a broad range of sophisticated therapeutic products for stroke, heart attack, obesity, cardiac arrhythmia, and gynecology. The companies include:

• Leptos Biomedical, Inc.
• INNERCOOL therapies, Inc. (acquired by Cardium Therapeutics)
• CryoGen, Inc. (acquired by American Medical Systems)
• CryoCor, Inc. (spinout of CryoGen; NASDAQ:CRYO)